Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Geritol × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Prostatic Intraepithelial Neoplasia 1 Neoplasms 1 Eye Diseases 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Cardiovascular Diseases 1

Interventions

enzalutamide 1 beta Carotene 1 Vitamin E 1 Prednisone 1 Gonadotropin-Releasing Hormone 1 Geritol 1 Behavior Therapy 1 Ascorbic Acid 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00270647 2018-02-28

PHS II

Brigham and Women's Hospital

Phase NA Completed

14,641 enrolled

GastrointestinalGenitourinary

Cardiovascular Diseases, Eye Diseases, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡